Spironolactone management of resistant hypertension

JC Marrs - Annals of Pharmacotherapy, 2010 - journals.sagepub.com
Objective: To review the pharmacology, pharmacokinetics, pharmacodynamics, efficacy
data, and adverse effects of spironolactone in the treatment of resistant hypertension. Data …

[HTML][HTML] Clinical efficacy of spironolactone for resistant hypertension: a meta analysis from randomized controlled clinical trials

H Guo, Q Xiao - International journal of clinical and experimental …, 2015 - ncbi.nlm.nih.gov
Objectives: This study sought to determine the current effectiveness and safety of
spironolactone for resistant hypertension. Methods: Pubmed, EMBASE and Cochrane …

The effect of low-dose spironolactone on resistant hypertension

M Engbaek, M Hjerrild, J Hallas, IA Jacobsen - Journal of the American …, 2010 - Elsevier
Our objective was to estimate the effect of addition of low-dose spironolactone to previous
antihypertensive therapy in patients with resistant hypertension. Patients had 25 to 50 mg of …

Efficacy of spironolactone therapy in patients with true resistant hypertension

F de Souza, E Muxfeldt, R Fiszman, G Salles - Hypertension, 2010 - Am Heart Assoc
The role of spironolactone in resistant hypertension management is unclear. The aim of this
prospective trial was to evaluate the antihypertensive effect of spironolactone in patients with …

Low-dose spironolactone in the management of resistant hypertension: a surveillance study

DA Lane, S Shah, DG Beevers - Journal of hypertension, 2007 - journals.lww.com
Methods We have conducted an open observational study of the use of spironolactone 25–
50 mg in the management of patients with resistant hypertension. This drug was …

A meta-analysis of add-on use of spironolactone in patients with resistant hypertension

D Zhao, H Liu, P Dong, J Zhao - International journal of cardiology, 2017 - Elsevier
Objective The efficacy of add-on use of spironolactone in patients with resistant
hypertension has been investigated in several small studies. We performed this meta …

Efficacy and safety of spironolactone in patients with resistant hypertension: a meta-analysis of randomised controlled trials

C Wang, B Xiong, J Huang - Heart, Lung and Circulation, 2016 - Elsevier
Background The treatment of resistant hypertension (RH) is challenging. Several
observational studies have suggested that the addition of spironolactone to triple-drug …

[HTML][HTML] Clinical efficacy and safety of spironolactone in patients with resistant hypertension: a systematic review and meta-analysis

C Chen, XY Zhu, D Li, Q Lin, K Zhou - Medicine, 2020 - journals.lww.com
Background: We conducted a meta-analysis to summarize all available evidence from
randomized controlled trial studies regarding the clinical efficacy and safety of …

Addition of spironolactone in patients with resistant hypertension: a meta-analysis of randomized controlled trials

L Liu, B Xu, Y Ju - Clinical and Experimental Hypertension, 2017 - Taylor & Francis
This study was designed to assess the effect of additional spironolactone on blood pressure
in patients with resistant hypertension. MEDLINE, EMBASE, and Cochrane Library were …

Spironolactone and resistant hypertension

JS Williams - Nature Reviews Endocrinology, 2010 - nature.com
True resistant hypertension is relatively frequent, yet effective treatment is often difficult to
identify. In a new study, de Souza and colleagues demonstrate the potent blood pressure …